Thursday, May 6, 2021

Tag: Clinical Trial

Antibiotic could help with spinal cord injury paralysis

Researchers have found that a commonly prescribed antibiotic could be used to help prevent paralysis and other long-term Functional deficits associated with a partial spinal cord injury (SCI). Researchers in the field have known...

Human clones verified

For the first time, scientists have achievedhuman "therapeutic cloning," creating human embryos through cloning and extracting stem cells that were thenmorphed into other kinds of cells. The stunning announcement, being made today by South...

Researchers: Don’t try to clone babies

The South Korean researchers who made history this week in creating human embryos through cloning and extracting viable stem cells say they adamantly oppose cloning to make babies. "We are in the position against reproductive...

Scientists create human embryos through cloning, extract embryonic stem cells

For the first time, scientists have achievedhuman "therapeutic cloning," creating human embryos through cloning and extracting stem cells that were thenmorphed into other kinds of cells. The stunning announcement, being made today by Korean scientists...

Current Interventions 2004

Drug Therapy Effective drug therapy for spinal cord injury first became a reality in 1990, when methylprednisolone, the first drug shown to improve recovery from spinal cord injury, moved from clinical trials to standard use....

Severed spinal cord regenerated

Scientists have succeeded in restoring movement to rats paralysed by spinal injuries. The breakthrough could ultimately lead to new treatments for people who have been paralysed by damage to their spinal cord. Spinal cord injuries...

Phase II Trials of ProCord

Proneuron Biotechnologies Teams with Craig Hospital in Denver to Expand IND Phase II Trial of ProCord for the Treatment of Spinal Cord Injuries to the U.S. Following tissue injury, a type of white blood cell,...

ProNeuron to test spinal cord treatment in U.S.

NEW YORK (Reuters) - ProNeuron Biotechnologies Inc. on Monday said it was beginning U.S. clinical trials of an ambitious new drug aimed at improving the condition of patients who would otherwise remain paralyzed throughout...

New study may explain spinal cord pain

BY PAULA BRADY - Staff Reporter A new study by Yale researchers has found a possible explanation for chronic pain in patients with spinal cord injuries. Conduction of signals in nerve cells is controlled by molecular...

Blocking immune response to spinal cord injury can improve chances for recovery

People who suffer spinal cord injuries may have a greater chance of recovery if treated with drugs that block the body’s own Immune Response to the initial trauma, researchers from the Reeve-Irvine Research Center...